Literature DB >> 19655228

The use of sacral neuromodulation for the treatment of non-obstructive urinary retention secondary to Guillain-Barré syndrome.

Matthew S Wosnitzer1, Rhonda Walsh, Matthew P Rutman.   

Abstract

Guillain-Barré syndrome, an acute autoimmune polyneuropathy and demyelinating disease, is characterized by weakness, sensory loss, areflexia, pain, autonomic dysfunction, and occasionally, micturition disturbances including voiding difficulty, urinary retention, nocturnal urinary frequency, and urge incontinence. Typically, urinary dysfunction resolves simultaneously with other neurologic deficits. We report the case of a 20-year-old woman with Guillain-Barré syndrome and persistent urinary retention 18 months following initial diagnosis. This patient is the first described in the literature to undergo successful treatment with sacral neuromodulation. Immediately following neuromodulator placement, the patient voided spontaneously and has had no voiding dysfunction or postvoid residual after 5 months of follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19655228     DOI: 10.1007/s00192-009-0826-9

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  5 in total

1.  Guillain-Barré syndrome presenting with urinary retention and hypertension.

Authors:  Alexandra E Labovitz; Henry H Mangurten
Journal:  Clin Pediatr (Phila)       Date:  2004-09       Impact factor: 1.168

2.  The urodynamic aspects of the Guillain-Barré syndrome.

Authors:  J S Wheeler; M B Siroky; A Pavlakis; R J Krane
Journal:  J Urol       Date:  1984-05       Impact factor: 7.450

3.  Micturitional disturbance in patients with Guillain-Barré syndrome.

Authors:  R Sakakibara; T Hattori; S Kuwabara; T Yamanishi; K Yasuda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

4.  Magnetic resonance imaging of the cauda equina in Guillain-Barré syndrome.

Authors:  P B Crino; R Zimmerman; D Laskowitz; E C Raps; A M Rostami
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

5.  Urinary retention secondary to Landry-Guillain-Barré syndrome.

Authors:  B A Kogan; M H Solomon; A C Diokno
Journal:  J Urol       Date:  1981-11       Impact factor: 7.450

  5 in total
  1 in total

1.  Guillain-Barré syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort.

Authors:  Bhasker Amatya; Fary Khan; Michael Whishaw; Julie F Pallant
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.